Senior Director, Investor Relations & Communications

Lyell Immunopharma, a clinical-stage biotech, is seeking a Director or Senior Director of Investor Relations and Communications. The role translates complex science and clinical data into compelling narratives for investors, analysts, media, and the financial community.
You will collaborate with C-suite and product teams, manage press materials, earnings filings, conferences and roadshows, and ensure regulatory compliance.

#J-18808-Ljbffr